Kenvue /$KVUE
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Kenvue
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.
Ticker
$KVUE
Sector
Trading on
NYSE
Industry
Personal Care Products
Headquarters
Employees
22,000
ISIN
US49177J1025
Website
Kenvue Metrics
BasicAdvanced
$42B
39.26
$0.55
0.97
$0.82
3.79%
Price and volume
Market cap
$42B
Beta
0.97
52-week high
$25.17
52-week low
$17.67
Average daily volume
19M
Dividend rate
$0.82
Financial strength
Current ratio
0.857
Quick ratio
0.505
Long term debt to equity
63.513
Total debt to equity
88.043
Dividend payout ratio (TTM)
147.82%
Interest coverage (TTM)
6.76%
Management effectiveness
Return on assets (TTM)
6.77%
Return on equity (TTM)
10.22%
Valuation
Price to earnings (TTM)
39.256
Price to revenue (TTM)
2.709
Price to book
4.13
Price to tangible book (TTM)
-5.42
Price to free cash flow (TTM)
28.708
Dividend yield (TTM)
3.79%
Forward dividend yield
3.79%
Growth
Revenue change (TTM)
-1.19%
Earnings per share change (TTM)
-29.62%
What the Analysts think about Kenvue
Analyst ratings (Buy, Hold, Sell) for Kenvue stock.
Kenvue Financial Performance
Revenues and expenses
Kenvue Earnings Performance
Company profitability
Kenvue News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Kenvue stock?
Kenvue (KVUE) has a market cap of $42B as of June 06, 2025.
What is the P/E ratio for Kenvue stock?
The price to earnings (P/E) ratio for Kenvue (KVUE) stock is 39.26 as of June 06, 2025.
Does Kenvue stock pay dividends?
Yes, the Kenvue (KVUE) stock pays dividends to shareholders. As of June 06, 2025, the dividend rate is $0.82 and the yield is 3.79%. Kenvue has a payout ratio of 147.82% on a trailing twelve-month basis.
When is the next Kenvue dividend payment date?
The next Kenvue (KVUE) dividend payment date is unconfirmed.
What is the beta indicator for Kenvue ?
Kenvue (KVUE) has a beta rating of 0.97. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.